News & Updates
Filter by Specialty:
EAGLE trials herald new era for uncomplicated UTI treatment
Oral gepotidacin, an investigational, first-in-class oral antibiotic with a novel mechanism of action, showed favourable signals for the treatment of uncomplicated urinary tract infections (uUTIs), according to the results of two phase III trials.
EAGLE trials herald new era for uncomplicated UTI treatment
25 Apr 2023Maximal transurethral resection tied to better outcomes at cystectomy
Pathological response at cystectomy may improve with maximal resection in patients undergoing transurethral resection for muscle-invasive bladder cancer prior to neoadjuvant chemotherapy, according to a study.
Maximal transurethral resection tied to better outcomes at cystectomy
19 Apr 2023MV-140 vaccine proven safe, effective in recurrent UTI
Immunotherapy with MV-140 (Uromune) successfully prevents urinary tract infections (UTIs) in patients suffering from recurrent UTIs, suggest the results of a prospective study presented at the 38th Annual EAU Congress (EAU 2023).
MV-140 vaccine proven safe, effective in recurrent UTI
18 Apr 2023Investigational imaging agent holds promise for diagnosing renal cancer
In the pivotal phase III ZIRCON study, PET/CT imaging with 89Zr-DFO-girentuximab, an investigational imaging agent, demonstrated potential in the noninvasive identification of clear-cell renal cell carcinoma (ccRCC) in patients with indeterminate renal masses (IDRM).